Skip to content
Home
About Us
Activities
Products
Current Products
Oncology
Chemotherapy
Antiemetics
Bisphosphonate
Thrombopoirtics
Immunomodulators
Hormone Therapy
Targeted Therapy
Anti-Cancer
Hematology
Kinase Inhibitors
Cardiology
Anticoagulant
Antiplatelet Agent
Antiarrythmic
Diagnostic Agents
Upcoming
International
Conferences
Principles
Career
Contact us
Menu
Home
About Us
Activities
Products
Current Products
Oncology
Chemotherapy
Antiemetics
Bisphosphonate
Thrombopoirtics
Immunomodulators
Hormone Therapy
Targeted Therapy
Anti-Cancer
Hematology
Kinase Inhibitors
Cardiology
Anticoagulant
Antiplatelet Agent
Antiarrythmic
Diagnostic Agents
Upcoming
International
Conferences
Principles
Career
Contact us
Whats New 💥
Close
Bortezomib
Generic Name:
Bortezomib
Therapeutic Segment:
Antineoplastic agents
Indications:
Multiple Myeloma
Strength & Dosage Form:
3.5mg tablet
PRESCRIBING INFORMATION
